Skip to content

A comparison between LMA protector and I-gel in adult patients undergoing surgery under general anesthesia

Comparison between LMA protector and I-gel in adults patients undergoing surgery under general anaesthesia with controlled ventilation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065055
Enrollment
84
Registered
2024-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N209- Urinary calculus, unspecified

Interventions

Intervention1: Time of insertion 2. Ease of insertion 3. First attempt success rate 4. Fibre optic view obtained.: To also compare for a period less than 3 hour duration of the Fibre optic view obt

Sponsors

Amrita Institute of medical sciences and Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age – >18 years - ASA PS – I & II - Surgeries lasting for 3 hours or less

Exclusion criteria

Exclusion criteria: 1. Anticipated difficult airway 2. Risk of aspiration (full stomach, GERD, hiatus hernia, pregnancy), 3. BMI > 30 kg/m2 4. Surgery requiring lateral or prone position 5. Airway obstruction below larynx 6. Patients requiring postoperative ventilation 7. Laparoscopic surgeries

Design outcomes

Primary

MeasureTime frame
To compare the oropharyngeal pressure leak between LMA protector & Igel in adults undergoing general anesthesia.Timepoint: December 2023 to December 2024

Secondary

MeasureTime frame
To compare between the LMA protector & Igel in adults undergoing general anesthesia the 1.Time of insertion 2.Ease of insertion 3.Fiber optic view obtained 4.Incidence of post-operative sore throat at 24 hours 5.Blood staining of supraglottic airway 6.Any regurgitation detected using litmus paper 7. Intraoperative events : bronchospasm, larygospasm Timepoint: January 2023 to June 2024

Countries

India

Contacts

Public ContactDr Kripa Anna Thomas

Amrita Institute of Medical Sciences and Research Centre

kannathomas23@gmail.com8138906950

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026